Introduction to daily activities of clinical pharmacist.
Drug therapy monitoring,
Medication chart review
Clinical Progress
Pharmacist intervention
Detection and management of ADRs
Community pharmacy-Definition ,scope and Roles and responsibilities of commun...MerrinJoseph1
Second Pharm D , Community Pharmacy -first chapter,definition of community pharmacy,its scope and the roles and responsibilities of community pharmacist in health care of common people,Dr.Merrin Joseph,Department of pharmacy practice
Basic introduction to patient counselling for the clinical pharmacy services. Educating the patient on their disease, medication and lifestyle for better patient care and quicker recovery.
Drug distribution is one of the basic service provided by the hospital pharmacy.
Drug distribution system falls in to 3 categories -
1)Ward – controlled system
2)Pharmacy controlled imprest based system
3)Pharmacy controlled patient issue system
Use of computers in hospital pharmacy, biostatistics and research methodology...shaistasumayya2
Computers in pharmacy are used for the information of drug data, records and files, drug management (creating, modifying, adding and deleting data in patient files to generate reports), business details.
Hospital Formulary - presentation gives the detail idea about Hospital formulary, its advantage, disadvantage, how to prepare Hospital formulary and much more. this will be useful for Pharm.D-IV YEAR students, which was in their Hospital pharmacy subject. regards APOLLOJAMES
Introduction to daily activities of clinical pharmacist.
Drug therapy monitoring,
Medication chart review
Clinical Progress
Pharmacist intervention
Detection and management of ADRs
Community pharmacy-Definition ,scope and Roles and responsibilities of commun...MerrinJoseph1
Second Pharm D , Community Pharmacy -first chapter,definition of community pharmacy,its scope and the roles and responsibilities of community pharmacist in health care of common people,Dr.Merrin Joseph,Department of pharmacy practice
Basic introduction to patient counselling for the clinical pharmacy services. Educating the patient on their disease, medication and lifestyle for better patient care and quicker recovery.
Drug distribution is one of the basic service provided by the hospital pharmacy.
Drug distribution system falls in to 3 categories -
1)Ward – controlled system
2)Pharmacy controlled imprest based system
3)Pharmacy controlled patient issue system
Use of computers in hospital pharmacy, biostatistics and research methodology...shaistasumayya2
Computers in pharmacy are used for the information of drug data, records and files, drug management (creating, modifying, adding and deleting data in patient files to generate reports), business details.
Hospital Formulary - presentation gives the detail idea about Hospital formulary, its advantage, disadvantage, how to prepare Hospital formulary and much more. this will be useful for Pharm.D-IV YEAR students, which was in their Hospital pharmacy subject. regards APOLLOJAMES
Acquiring and representing drug-drug interaction knowledge and evidence, Litm...jodischneider
Presentation to Diane Litman's lab at the University of Pittsburgh about modeling and acquiring evidence for the Drug Interaction Knowledge Base (DIKB) project.
Contribution of metabolites to the drug drug interactionRx Ravi Goyani
1. The contribution of drug metabolites to the drug drug interaction presented by RAVI GOYANI M.S(Pharm)pharmaceutics(NIPER).
2. Contents of the presentation: Introduction, Drug-drug interaction, regulatory perspectives of drug-drug interaction, potential pharmacokinetic interaction produced by metabolites, case study, evaluation of metabolites to drug interaction, conclusion , references.
3. Introduction of metabolites and its examples.
4.Types of metabolites and how its formation in to the body by phase 1&2 metabolism.
5.Types of drug drug interaction.
6.7. Short discussion about the pharmacokinetics drug interation which are essential for the preclinical pharmacokinetics drug interaction.
8. Regulatory perspective on the metabolites contribution to the drug drug interaction.
9. Criteria for the absence of a based drug interaction on the results of a clinical study.
10.11.12. Case study of the some drug metabolites(efavirenz, verapamil) participate in to the drug drug interaction by the known mechanism such as irreversible of CYP 450 enzymes bye protein adduct formation or intermediate complex formation.
13. Evaluation of metabolites drug interaction by following study.
1. Estimation of metabolites concentration
2. Metabolites and parent cytochrome P450 inhibition potency comparison
3. RMet strategy
14.15.16. Brief discussion about the evaluation and specific criteria for that evaluation parameters which are considering for the metabolites drug interaction.
17. Proposed algorithm for the evaluation of drug metabolites interaction.
18. Conclusion.
19. List of references.
Presentation gives an overview of the inter-relationship between nutrition and pharmacy. Its importance is an imperative consideration in patient care. The presentation begins with an introduction to both areas but then focuses on specific drug-nutrient interactions with specific drug categories.
Identify primary drug interaction concepts
Describe types and mechanisms of interactions
Identify drug interactions commonly encountered with antiretroviral drugs
Describe how to manage known interactions
A drug interaction is a situation in which a substance affects the activity of a drug, i.e. the effects are increased or decreased, or they produce a new effect that neither produces on its own.
Polypharmacy and Rational Prescribing in Elderly Patients.pptxAhmed Mshari
Polypharmacy is typically defined as the prescription of five or more medications.
It also refers to the prescription of medications that do not have a specific current indication, that duplicate other medications, or that are known to be ineffective for the condition being treated.
In other words, polypharmacy is the use of multiple medications that are unnecessary and have the potential to do more harm than good.
Prescription drug abuse is an epidemic in the Appalachian region that is impacting public health, education, economic development and family life. This talk will examine epidemiologic factors associated with prescription and over-the-counter drug misuse. Commonly abused prescription and over-the-counter drugs will be discussed and safe patient and prescriber factors that can increase the risk of prescription drug abuse will be compared. The strengths and limitations of prescription-drug monitoring programs will be explained. Session participants will discuss actions they have taken in their community to fight prescription drug abuse.
Scope on medicatio error in a sample of iraqi two cities samawa and diwania.Ali Al Samawy
Summery
Introduction:
The pregnancy is sensitive period and administration of drugs may lead to threating of fetus life or cause malformations and teratogenicity etc.
Methodology:
A cross-sectional study of medication errors of 100 prescriptions dispensed to a pregnant women in a sample of Iraqi two cities (Al Sammawah & Al Diwania) during October, 2016.
A formal was used to collect data included the name of pregnant, age, trimester, doctor diagnosis, the drug dispensed and their dose, rout, duration, frequency, strength and notes section. The formal filled during visits of the research team to pharmacies that most of the prescriptions they dispense are for pregnant women prescribed by a nearby gynecology &obstruct doctors.
Then the data analyzed to identify the medication errors that includes; inappropriate and irrational, ineffective, over and under prescribing and drug interactions using available literature and drugs.com drug interaction checker.
Result:
Total number of prescriptions involved in the study is 100 prescriptions, they contain 487 medication dispensed to the patients. The total number of medication errors identified were 364(74.7%), included 110 irrational & inappropriate prescribing, 47 over prescribing. 19 under prescribing, and 8 ineffective prescribing. The drug interactions were classified to drug-drug interactions 126 interactions identified and drug food interactions 54 interactions were recorded. 0.8 % of all drug-drug interactions were major, 76 % moderate and 23% mild. Phenobarbital (luminal) is the drug that caused the most of medication error that identified as it dispensed 23 times but in all of these patient luminal was irrational and inappropriate and it caused the most of interactions recorded as 44 interactions were caused by luminal.
While Dydrogesterone was prescribed as a tocolytic 21 times, and this considered as irrational & inappropriate prescribing. Isoxsuprine prescribed irrationally 17 times. The parenteral iron administered without calculating the dose depending on the body weight and blood Hb. Most of antibiotics and antifungal prescribed for incorrect duration or dose. The other errors were related to other drugs duration, dose, and indication errors.
Conclusion:
Percentage of medication errors was high. Types of medication errors were mostly drug-drug interaction, irrational and inappropriate use. The impact of these medication errors may include teratogenic effect.
Recommendations:
Adherence to the treatment guidelines and further studies to assess the impact of medications errors on pregnant women and her fetus.
This slide contains the description of ADR, its dissimilarities with Side effects and toxic effects, types of ADRs, risk Factors and the description of Pharmacovigilance program.
NIMH i PSC Assays for the Drug Pipeline - Panchisionwef
Dr David Panchision's live presentation at the Schizophrenia Research Forum's live webinar of June 28, 2017 - http://www.schizophreniaforum.org/forums/webinar-modeling-neuropsychiatric-disorders-using-vitro-models
Schizophrenia Research Forum Live Webinar - June 28, 2017 - Rusty Gage wef
Fred Gage's live presentation at the Schizophrenia Research Forum's live webinar of June 28, 2017 - http://www.schizophreniaforum.org/forums/webinar-modeling-neuropsychiatric-disorders-using-vitro-models
SCHIZOPHRENIA RESEARCH FORUM - LIVE WEBINAR June 2017 Kristen Brennandwef
Kristen Brennand presentation at the live webinar of June 28, 2017 hosted by the Schizophrenia Research Forum (http://www.schizophreniaforum.org/forums/webinar-modeling-neuropsychiatric-disorders-using-vitro-models)
STRATEGIES FOR COMMUNICATION AND SENSITIVITY FOR PERSONS EXPERIENCING DEMENTI...wef
Live presentation recorded June 21, 2017, featuring Ellen Phipps and Devin Bowers - review additional material at www.alzpossible.org/strategies-for-communication/
Translating from Animal Models to Human Schizophrenia - Insights into Pathoph...wef
Presentation made by Dr. Tony Grace at the Schizophrenia Research Forum's live webinar of May 4, 2017 - Dopamine in Schizophrenia—Cortical and Subcortical Pathophysiology - review recording of session at http://www.schizophreniaforum.org/forums/dopamine-schizophrenia%E2%80%94cortical-and-subcortical-pathophysiology
Presentation made by Dr. Oliver Howes at the Schizophrenia Research Forum's live webinar of May 4, 2017 - Dopamine in Schizophrenia—Cortical and Subcortical Pathophysiology - review recording of session at http://www.schizophreniaforum.org/forums/dopamine-schizophrenia%E2%80%94cortical-and-subcortical-pathophysiology
Topography and functional significance of the dopaminesgic dysfunction in sch...wef
Presentation made by Dr. Anissa Abi-Dargham at the Schizophrenia Research Forum's live webinar of May 4, 2017 - Dopamine in Schizophrenia—Cortical and Subcortical Pathophysiology - review recording of session at http://www.schizophreniaforum.org/forums/dopamine-schizophrenia%E2%80%94cortical-and-subcortical-pathophysiology
SRF Webinar - What It Will Take to Make Coordinated Specialty Care Available ...wef
Presentation made March 22, 2017, during the live webinar hosted by Schizophrenia Research Forum (SRF). Event recording and additional slides at http://www.schizophreniaforum.org/forums/achieving-effective-treatment-early-psychosis-united-states
SRF Webinar: Beyond DUP - Addressing Disengagement in Community-based Early I...wef
Presentation made March 22, 2017, during the live webinar hosted by Schizophrenia Research Forum (SRF). Event recording and additional slides at http://www.schizophreniaforum.org/forums/achieving-effective-treatment-early-psychosis-united-states
Presentation made March 17, 2017 and hosted by AlzPossible - www.alzpossible.org.
Review recording at http://alzpossible.org/webinars-2/the-basics-memory-loss-dementia-and-alzheimers-disease/
Presentation made at the live webinar hosted by the Schizophrenia Research Forum on the 21st of February, 2017 - http://www.schizophreniaforum.org/forums/treatment-resistant-schizophrenia-new-guidelines-diagnosis-and-terminology
Oliver Howes - Treatment-Resistant Schizophrenia: New Guidelines on Diagnosis...wef
Presentation made at the live webinar hosted by the Schizophrenia Research Forum on the 21st of February, 2017 - http://www.schizophreniaforum.org/forums/treatment-resistant-schizophrenia-new-guidelines-diagnosis-and-terminology
John Kane - Treatment-Resistant Schizophrenia: New Guidelines on Diagnosis an...wef
Presentation made at the live webinar hosted by the Schizophrenia Research Forum on the 21st of February, 2017 - http://www.schizophreniaforum.org/forums/treatment-resistant-schizophrenia-new-guidelines-diagnosis-and-terminology
HEAR approach to behavior management Live webinar Feb 1 2017wef
Slides presented at the HEAR Approach to Behavior Management live webinar of February 1, 2017, featuring presentations from Dr. Andrew Heck and Carol Garby.
1. PREVENTING MEDICATION-RELATED
PROBLEMS
WEBINAR
Dec 5, 2007
Featuring
Patricia W. Slattum, PharmD, PhD,
and moderated by Ayn Welleford, PhD
Preventing Medication-Related Problems Virginia Alzheimer’s Commission AlzPossible Initiative
2. INTRODUCTION
Medications are probably the
single most important
health care technology
in preventing illness and disability in the older
population.
Avorn J., Health Affairs, Spring 1996
Preventing Medication-Related Problems Virginia Alzheimer’s Commission AlzPossible Initiative
3. "Any symptom in an elderly patient
should be considered a drug side
effect until proven otherwise."
J Gurwitz, M Monane, S Monane, J Avorn
Brown University Long-term Care Quality Letter 1995
Preventing Medication-Related Problems Virginia Alzheimer’s Commission AlzPossible Initiative
4. WHAT IS A MEDICATION-RELATED
PROBLEM?
Medication-Related Problem (MRP)
An undesirable event experienced
by a patient that involves or is
suspected to involve drug therapy
and actually or potentially
interferes with a desired patient
outcome.
Preventing Medication-Related Problems Virginia Alzheimer’s Commission AlzPossible Initiative
5. “SYMPTOMS” of MRPs
CHANGES IN SPEECH
FALLS
CONFUSION
LOSS OF DEPRESSION
APPETITE
“SYMPTOMS”
OF MRPs
WEAKNESS OR DELIRIUM
LETHARGY
INCONTINENCE INSOMNIA
PARKINSON’S-LIKE SYMPTOMS
Preventing Medication-Related Problems Virginia Alzheimer’s Commission AlzPossible Initiative
6. TYPES OF MRPs
Medical condition requires
new or additional drug Correct drug,
therapy that has not been dose too low.
prescribed.
Patient taking
Correct drug,
unnecessary drug given TYPES dose too high.
present condition.
OF MRPs
Wrong drug for
Adverse drug reaction
patient’s medical
or drug interaction.
condition or age.
Patient not taking
drug correctly.
Preventing Medication-Related Problems Virginia Alzheimer’s Commission AlzPossible Initiative
7. REASONS OLDER ADULTS ARE AT
GREATER RISK FOR MRPs
Multiple chronic diseases
Multiple medications
Multiple prescribers
Physiologic changes associated with aging
Under-representation in clinical
trials, particularly those over age 75
Shortage of professionals with specific
training to work with older adults
Preventing Medication-Related Problems Virginia Alzheimer’s Commission AlzPossible Initiative
8. REASONS MRPs ARE NOT ADDRESSED
The patient has been taking this medication
for many years without a problem.
One provider did not prescribe all of the
medications the patient is taking.
Patients and prescribers are concerned that
the risk of discontinuing the medication is
greater than the benefit.
Patients often resist changes in their drug
therapy (a stereotype).
The problems the patient is experiencing are
not usually seen with this medication.
Preventing Medication-Related Problems Virginia Alzheimer’s Commission AlzPossible Initiative
9. PREVENTING MRP
1 2 3
Communicate Designate a Keep a
with health medication medication list
care manager
providers
about
medications
Preventing Medication-Related Problems Virginia Alzheimer’s Commission AlzPossible Initiative
10. PREVENTING MRP
4 5 6
Consult with Use common Obtain refills
a doctor or sense when in a timely
pharmacist using manner
before taking medications
over-the-
counter
medication or
herbal
supplements
.
Preventing Medication-Related Problems Virginia Alzheimer’s Commission AlzPossible Initiative
11. TIPS FOR ADMINISTERING MEDICATIONS TO
PATIENTS WITH DEMENTIA
LANGUAGE Use clear and simple language.
ROUTINE Develop a routine.
Don’t assume the patient can manage
MANAGEMENT medications on their own.
ORGANIZATION Keep medications organized.
Adapt medication administration to the
ADMINISTRATION patient’s needs.
STORAGE Store medications safely.
Preventing Medication-Related Problems Virginia Alzheimer’s Commission AlzPossible Initiative
12. PANELISTS
Dr. Patricia Slattum graduated with a B.S. and Pharm.D. in Pharmacy, a Ph.D. in
Pharmaceutics, and a Certificate in Aging Studies from MCV/VCU. She received further
training as a geriatric pharmacy fellow at McGuire Department of Veterans Affairs
Medical Center in Richmond and as an NIH-funded postdoctoral fellow in aging and
drug disposition at the University of North Carolina at Chapel Hill. Dr. Slattum joined
the faculty at MCV/VCU School of Pharmacy in 1996, and is currently Associate
Professor and Vice Chair for Graduate Studies in the Department of Pharmacy/
Department of Pharmaceutics at VCU. Her primary responsibilities include professional
and graduate teaching, clerkship training and clinical program development in
assisted-living and community pharmacy practice, and geriatric clinical pharmacology
research focusing on central nervous system pharmacodynamics and medication-
related problems in the elderly. She is a member of the American Society for Clinical
Pharmacology and Therapeutics, the American Society of Consultant Pharmacists, the
American College of Clinical Pharmacy, the Gerontological Society of America, and the
American Geriatrics Society.
Ayn Welleford, PhD, is Chair, VCU Department of Gerontology, Associate
Professor,VCU Department of Gerontology, and Associate Director, Virginia Geriatric
Education Center. Dr. Welleford received her B.A. in Management/ Psychology from
Averett College, M.S. from the Department of Gerontology and Ph.D. in Developmental
Psychology from VCU. She has taught extensively in the areas of Lifespan
Development, and Adult Development and Aging. As an educator, researcher, and
previously as a practitioner she has worked with a broad spectrum of individuals across
the caregiving continuum. As a gerontologist she currently works extensively with
formal and informal caregivers to improve elder care through education.
Preventing Medication-Related Problems Virginia Alzheimer’s Commission AlzPossible Initiative